本文關(guān)鍵詞：運(yùn)用風(fēng)險(xiǎn)評(píng)估法預(yù)防控制血流感染　出處：《中華醫(yī)院感染學(xué)雜志》2016年18期 　論文類型：期刊論文

  更多相關(guān)文章： 血流感染 風(fēng)險(xiǎn)評(píng)估

【摘要】：目的運(yùn)用個(gè)性化風(fēng)險(xiǎn)評(píng)估表單預(yù)防控制血流感染。方法運(yùn)用風(fēng)險(xiǎn)評(píng)估法等手段,建立個(gè)性化的血流感染定量風(fēng)險(xiǎn)評(píng)估表單,通過(guò)隨機(jī)對(duì)照試驗(yàn)(RCT)的方式對(duì)118例患者進(jìn)行試驗(yàn),其中重癥醫(yī)學(xué)科1組(試驗(yàn)組)61例患者,重癥醫(yī)學(xué)科2組(對(duì)照組)57例患者為對(duì)照,以患者出科48h后作為患者觀察終點(diǎn),血流感染率作為衡量指標(biāo),比較兩組患者預(yù)防控制血流感染的臨床表現(xiàn),進(jìn)一步完善風(fēng)險(xiǎn)評(píng)估項(xiàng)目。結(jié)果個(gè)性風(fēng)險(xiǎn)評(píng)估表單在試驗(yàn)組與對(duì)照組中預(yù)防控制血流感染的作用存在明顯差異(χ2=37.21,P0.05)。結(jié)論個(gè)性化風(fēng)險(xiǎn)評(píng)估表單能夠通過(guò)預(yù)測(cè)感染對(duì)高風(fēng)險(xiǎn)項(xiàng)目進(jìn)行干預(yù),進(jìn)而預(yù)防血流感染的發(fā)生,但表單的制定是以綜合性醫(yī)院為背景,在�？漆t(yī)院進(jìn)行推行,結(jié)果會(huì)有一定的偏差。
[Abstract]:Objective to use personalized risk assessment form to prevent and control blood flow infection. A randomized controlled trial (RCTs) was conducted in 118 patients, including group 1 (61 patients in the experimental group) and group 2 (57 patients in the control group). The clinical manifestations of prevention and control of blood flow infection were compared between the two groups with 48 hours after the patients left the department as the observation end point and the blood flow infection rate as the measurement index. Results the effect of personality risk assessment form on preventing and controlling blood flow infection was significantly different between the experimental group and the control group (蠂 2 = 37.21). P0.05.ConclusionThe personalized risk assessment form can intervene in high risk items by predicting infection, and then prevent the occurrence of blood flow infection, but the form is made in general hospital as the background. Implementation in specialist hospitals will result in certain deviations.
【作者單位】： 第三軍醫(yī)大學(xué)第三附屬醫(yī)院野戰(zhàn)外科研究所感染控制科;
【基金】：重慶市基礎(chǔ)與前沿研究項(xiàng)目(cstc2014jcyjys10002)
【分類號(hào)】：R446.5;R197.323
【正文快照】： 血流感染(BSI)包括菌血癥、敗血癥和膿毒癥,是危及人類生命的全身性感染疾病,嚴(yán)重者可引起休克、彌散性血管內(nèi)凝血(DIC)、多臟器功能衰竭乃至死亡。美國(guó)每年發(fā)生敗血癥約750 000例,并導(dǎo)致大約215 000例死亡[1]。近年來(lái)隨著抗菌藥物、激素、免疫抑制劑等藥物的不合理應(yīng)用,以及，

本文編號(hào)：1428367